Should the indication of pneumococcal polysaccharide vaccine in children be definitively withdrawn?
作者信息
Martinón-Torres Federico
机构信息
Pediatric Infectious Disease and Vaccines Unit, Área Integrada de Pediatría, Hospital Clínico Universitario de Santiago de Compostela Genetics, Vaccines, Infections and Pediatrics Research Group, Healthcare Research Institute of Santiago de Compostela, Spain.
出版信息
Clin Infect Dis. 2014 Jul 1;59(1):138. doi: 10.1093/cid/ciu228. Epub 2014 Apr 9.
Abstract
摘要
相似文献
1
Should the indication of pneumococcal polysaccharide vaccine in children be definitively withdrawn?儿童肺炎球菌多糖疫苗的适应证是否应彻底取消？
Clin Infect Dis. 2014 Jul 1;59(1):138. doi: 10.1093/cid/ciu228. Epub 2014 Apr 9.
2
The challenge of preventing invasive pneumococcal disease in children with comorbid illnesses.预防合并其他疾病儿童侵袭性肺炎球菌疾病面临的挑战。
Clin Infect Dis. 2014 Feb;58(4):526-7. doi: 10.1093/cid/cit792. Epub 2013 Dec 2.
3
Advances in pneumococcal vaccines: the 13-valent pneumococcal conjugate vaccine received market authorization in Europe.肺炎球菌疫苗的进展：13价肺炎球菌结合疫苗在欧洲获得市场授权。
Expert Rev Vaccines. 2010 Mar;9(3):229-36. doi: 10.1586/erv.10.6.
4
The evidence for use of pneumococcal conjugate over polysaccharide in children.用于儿童的肺炎球菌结合疫苗而非多糖疫苗的证据。
Hum Vaccin Immunother. 2013 Jun;9(6):1385-6. doi: 10.4161/hv.24688. Epub 2013 May 31.
5
No Benefit to Delaying Pneumococcal Polysaccharide Vaccination in HIV-Positive Adults.对HIV阳性成人延迟接种肺炎球菌多糖疫苗无益处。
J Infect Dis. 2015 Dec 1;212(11):1851-2. doi: 10.1093/infdis/jiv349. Epub 2015 Jun 24.
6
Invasive pneumococcal disease, comorbidities, and polysaccharide vaccine use in children aged 5-15 years in England and Wales.英格兰和威尔士 5-15 岁儿童侵袭性肺炎球菌病、合并症和多糖疫苗使用情况。
Clin Infect Dis. 2014 Feb;58(4):517-25. doi: 10.1093/cid/cit791. Epub 2013 Dec 2.
7
[Two pneumococcal vaccines: the 7-valent conjugate vaccine (Prevenar) for children up to the age of 5 years and the 23-valent polysaccharide vaccine (Pneumo 23) for the elderly and specific groups at risk].[两种肺炎球菌疫苗：用于5岁以下儿童的7价结合疫苗（沛儿）和用于老年人及特定高危人群的23价多糖疫苗（纽莫法23）]
Ned Tijdschr Geneeskd. 2007 Aug 18;151(33):1853-4; author reply 1854.
8
Safety of varying dosages of 7-valent pneumococcal protein conjugate vaccine in seniors previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.7价肺炎球菌蛋白结合疫苗不同剂量在先前接种过23价肺炎球菌多糖疫苗的老年人中的安全性。
Vaccine. 2005 May 25;23(28):3697-703. doi: 10.1016/j.vaccine.2005.02.017.
9
Pneumococcal polysaccharide vaccine efficacy and routine use of conjugate vaccines in infants: there is no need for a vaccine program in older adults at present.肺炎球菌多糖疫苗的效力及婴儿期结合疫苗的常规使用：目前老年人群无需疫苗接种计划。
Clin Infect Dis. 2012 Dec;55(11):1577-9; author reply 1579-81. doi: 10.1093/cid/cis700. Epub 2012 Aug 17.
10
13-valent pneumococcal vaccine: 50 years of age and older.
Prescrire Int. 2013 Feb;22(135):38.
本文引用的文献
1
Decreased immune response to pneumococcal conjugate vaccine after 23-valent pneumococcal polysaccharide vaccine in children.儿童接种 23 价肺炎球菌多糖疫苗后对肺炎球菌结合疫苗的免疫应答降低。
Vaccine. 2014 Jan 9;32(3):417-24. doi: 10.1016/j.vaccine.2013.11.029. Epub 2013 Dec 2.
2
Invasive pneumococcal disease, comorbidities, and polysaccharide vaccine use in children aged 5-15 years in England and Wales.英格兰和威尔士 5-15 岁儿童侵袭性肺炎球菌病、合并症和多糖疫苗使用情况。
Clin Infect Dis. 2014 Feb;58(4):517-25. doi: 10.1093/cid/cit791. Epub 2013 Dec 2.
3
Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).免疫功能低下儿童（6-18 岁）中 13 价肺炎球菌结合疫苗和 23 价肺炎球菌多糖疫苗的使用：免疫实践咨询委员会（ACIP）的建议。
MMWR Morb Mortal Wkly Rep. 2013 Jun 28;62(25):521-4.
Zotero 插件